Self-differentiated Dendritic Cells Presenting NY-ESO-1 Prime Cytotoxic T Cells for the Treatment of Multiple Myeloma
SD-DC-NY effectively primes cytotoxic T-lymphocytes and enhances antitumor activity against NY-ESO-1-positive MM cells, supporting NY-ESO-1 as an immunotherapeutic target and highlighting SD-DC-NY as a promising platform for MM immunotherapy.
Authors
- Sanya Sukpanichnant (ORCID: https://orcid.org/0000-0002-9724-2692)
- Wannasiri Chiraphapphaiboon (ORCID: https://orcid.org/0000-0002-4244-4895)
- Danai Samutpradit
- Ployploen Phikulsod (ORCID: https://orcid.org/0000-0001-5389-1896)
- Yupanun Wutti-In
- Pranaidej Hengswat
- Mutita Junking (ORCID: https://orcid.org/0000-0002-8347-3000)
- Nattaporn Phanthaphol
- Phurin Areesawangkit
- Pa-thai Yenchitsomanus
- KORNKAN CHOOME
- THAWEESAK CHIEOCHANSIN
Institutions
- Siriraj Hospital (TH)
- Mahidol University (TH)
- Instituto de Investigación Sanitaria de Santiago (ES)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-12-30
- DOI
- https://doi.org/10.21873/anticanres.17939
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00